Trial Profile
Safety and Efficacy of Treating Refractory Cancers With the Litx System: Phase II Safety and Efficacy Study in Patients With Liver Metastases From Colorectal Cancer That Have Failed Chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2006
Price :
$35
*
At a glance
- Drugs Talaporfin (Primary)
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- 28 Sep 2006 Status change
- 18 Sep 2005 New trial record.